Sargent Bickham Lagudis’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $6.22K | Hold |
37
| – | – | ﹤0.01% | 780 |
|
|
2022
Q3 | $7K | Sell |
37
-13
| -26% | -$2.46K | ﹤0.01% | 740 |
|
|
2022
Q2 | $10K | Buy |
50
+13
| +35% | +$2.6K | ﹤0.01% | 690 |
|
|
2022
Q1 | $9K | Hold |
37
| – | – | ﹤0.01% | 724 |
|
|
2021
Q4 | $8K | Hold |
37
| – | – | ﹤0.01% | 742 |
|
|
2021
Q3 | $7K | Hold |
37
| – | – | ﹤0.01% | 764 |
|
|
2021
Q2 | $8K | Hold |
37
| – | – | ﹤0.01% | 739 |
|
|
2021
Q1 | $8K | Hold |
37
| – | – | ﹤0.01% | 735 |
|
|
2020
Q4 | $7K | Hold |
37
| – | – | ﹤0.01% | 696 |
|
|
2020
Q3 | $6K | Hold |
37
| – | – | ﹤0.01% | 635 |
|
|
2020
Q2 | $6K | Hold |
37
| – | – | ﹤0.01% | 624 |
|
|
2020
Q1 | $6K | Sell |
37
-31
| -46% | -$5.03K | ﹤0.01% | 619 |
|
|
2019
Q4 | $14K | Buy |
68
+31
| +84% | +$6.38K | ﹤0.01% | 567 |
|
|
2019
Q3 | $8K | Hold |
37
| – | – | ﹤0.01% | 588 |
|
|
2019
Q2 | $7K | Sell |
37
-35
| -49% | -$6.62K | ﹤0.01% | 625 |
|
|
2019
Q1 | $12K | Hold |
72
| – | – | ﹤0.01% | 582 |
|
|
2018
Q4 | $14K | Hold |
72
| – | – | ﹤0.01% | 539 |
|
|
2018
Q3 | $12K | Hold |
72
| – | – | ﹤0.01% | 578 |
|
|
2018
Q2 | $12K | Hold |
72
| – | – | ﹤0.01% | 556 |
|
|
2018
Q1 | $12K | Sell |
72
-76
| -51% | -$12.7K | ﹤0.01% | 546 |
|
|
2017
Q4 | $22K | Buy |
148
+111
| +300% | +$16.5K | ﹤0.01% | 476 |
|
|
2017
Q3 | $5K | Hold |
37
| – | – | ﹤0.01% | 690 |
|
|
2017
Q2 | $5K | Buy |
+37
| New | +$5K | ﹤0.01% | 651 |
|
|
2016
Q3 | – | Sell |
-45
| Closed | -$4K | – | 733 |
|
|
2016
Q2 | $4K | Buy |
+45
| New | +$4K | ﹤0.01% | 623 |
|